NCT03516682 (REDIVAC-LB) is a NA clinical trial of Reminders in Communicable Disease, sponsored by Kaiser Permanente.

Who is sponsoring NCT03516682?

NCT03516682 is sponsored by Kaiser Permanente.

What drugs are being tested in NCT03516682?

Interventions in NCT03516682: Reminders.

What condition does NCT03516682 study?

NCT03516682 studies Communicable Disease.

Is NCT03516682 still recruiting?

NCT03516682 is currently completed. Last updated 7 August 2019.

Last reviewed 2019-08-07 · How we verify

NCT03516682: REDIVAC-LB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reducing Delay in Vaccination of Children: Logistic Barriers

Completed NA Last updated 7 August 2019

What this trial tests

NA trial testing Reminders in Communicable Disease in 250 participants. Completed in 31 March 2019.

Timeline

1 June 2018

Primary endpoint
31 March 2019

31 March 2019

Quick facts

Lead sponsor	Kaiser Permanente
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	250
Start date	1 June 2018
Primary completion	31 March 2019
Estimated completion	31 March 2019
Sites	1 location across United States

Drugs / interventions tested

Reminders

Conditions studied

Communicable Disease — all drugs for Communicable Disease →

Sponsor

Kaiser Permanente — full company profile →

Who can join

Adults 1 Month to 11 Months, any sex, with Communicable Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will assess the impact of automated reminders for the 6 month and 12 month vaccine visits to increase vaccination in parents experiencing logistic barriers to vaccination.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Targeted client communication via mobile devices for improving maternal, neonatal, and child health.
Palmer MJ, Henschke N, Bergman H, Villanueva G, et al · · 2020 · cited 30× · PMID 32813276 · DOI 10.1002/14651858.cd013679
Addressing logistical barriers to childhood vaccination using an automated reminder system and online resource intervention: A randomized controlled trial.
Wagner NM, Dempsey AF, Narwaney KJ, Gleason KS, et al · · 2021 · cited 11× · PMID 34059372 · DOI 10.1016/j.vaccine.2021.05.053

Verify or expand the search:

Other trials of Reminders

Trials testing the same drug.

NCT06300242 — Incentives for Influenza Vaccination · NA · completed
NCT06746090 — Improvement in Class II Molar Relationship Among Orthodontic Patients Reminded Through Text Message and Phone Call as Co · NA · completed
NCT05021224 — Engaging Suicidal Patients in Mental Health Treatment · NA · completed
NCT04147546 — Additional Screening With Sensitives RDTs and Malaria · Phase 3 · completed
NCT05093309 — Preventing Opioid Overdose Deaths by Empowering Pharmacists to Dispense Naloxone · NA · completed

Other recruiting trials for Communicable Disease

Currently open trials in the same condition.

NCT05870150 — Challenge Non-Typhoidal Salmonella (CHANTS) Study · NA · active not recruiting
NCT04256798 — Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery · Phase 3 · recruiting
NCT03225586 — Prospective Urban Rural Epidemiology Study · recruiting

Other Kaiser Permanente trials

Trials by the same sponsor.

NCT07522645 — Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Dis · NA · not yet recruiting
NCT07474038 — AI-Supported Cognitive Rehabilitation for Older Adults With Mild Cognitive Impairment · NA · enrolling by invitation
NCT07467668 — Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure · NA · not yet recruiting
NCT07216859 — Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI) · NA · not yet recruiting
NCT07264062 — MetSense Pilot and Feasibility · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03516682 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kaiser Permanente
Last refreshed: 7 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03516682.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing